Kodama Chemical IndustryKODAMA CHEMICAL INDUSTRY CO.,LTD.4222東証スタンダード化学FY ending Mar 2026, consolidated, J-GAAP
Out of every ¥100 of sales, about ¥3 is left as operating profit. Revenue changed +422.1% from the prior year, operating profit +1549.8%.
Net margin × asset turnover = ROA; ROA × financial leverage = ROE
Denominators: average assets and average equity. Derived from reported values; ROE is shown only for positive profit and equity.
| Period | Net margin | Asset turnover | ROA | Financial leverage | ROE |
|---|---|---|---|---|---|
| 2022 | 2.8% | 1.16× | 3.2% | 3.66× | 11.8% |
| 2023 | 1.2% | 1.17× | 1.4% | 3.65× | 5.3% |
| 2024 | — | —× | -1.7% | —× | — |
| 2025 | — | —× | -0.9% | —× | — |
| 2026 | 28.5% | 2.04× | 58.0% | 2.71× | 156.9% |
Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.
Annual trends in tangible-asset ratios and goodwill balance.
Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition
Track R&D investment and how long operating capital remains tied up before sales turn into cash.
R&D is shown only for years with machine-readable disclosure. Days are estimates using year-end receivables, inventory and payables divided by annual revenue or cost of sales; financial companies are excluded.
| Item | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 | FY ending Mar 2025 | FY ending Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 14,885 | 15,390 | 14,697 | 15,842 | 82,708 |
| Cost of revenue | 12,518 | 13,171 | 12,562 | 13,398 | 72,482 |
| Gross profit | 2,367 | 2,218 | 2,135 | 2,444 | 10,226 |
| SG&A | 1,689 | 1,837 | 1,969 | 2,282 | 7,546 |
| Operating income | 678 | 381 | 165 | 162 | 2,680 |
| Pretax income | 579 | 432 | 9 | 98 | 24,176 |
| Income tax | 62 | 109 | 141 | 100 | 465 |
| Net income attributable to owners | 417 | 189 | -244 | -133 | 23,534 |
| Operating margin | 4.6% | 2.5% | 1.1% | 1.0% | 3.2% |
Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.
Each bar totals 100% of assets; other is the residual.
| Item | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 | FY ending Mar 2025 | FY ending Mar 2026 |
|---|---|---|---|---|---|
| Cash and equivalents | ¥1.77B | ¥1.32B | ¥1.53B | ¥981.5M | ¥10.9B |
| Total assets | ¥12.9B | ¥13.4B | ¥14.6B | ¥14.1B | ¥67.1B |
| Net assets | ¥4.47B | ¥4.95B | ¥5.24B | ¥5.47B | ¥30.3B |
| Share capital | ¥100M | ¥100M | ¥100M | ¥100M | ¥100M |
| Trade receivables | ¥2.68B | ¥2.71B | ¥2.59B | ¥2.46B | ¥9.3B |
| Property, plant and equipment | ¥6.53B | ¥7.1B | ¥7.98B | ¥7.76B | ¥31.5B |
| Intangible assets excluding goodwill | ¥100M | ¥89M | ¥80M | ¥70.4M | ¥275.5M |
| Investment securities | ¥305.3M | ¥333.1M | ¥583.2M | ¥737.4M | ¥460.4M |
| Current assets | ¥5.91B | ¥5.78B | ¥5.9B | ¥5.45B | ¥32.8B |
| Current liabilities | ¥7.44B | ¥7.86B | ¥6.51B | ¥7.83B | ¥19B |
| Trade payables | ¥1.81B | ¥1.84B | ¥1.6B | ¥1.69B | ¥6.87B |
| Short-term borrowings | ¥4.03B | ¥3.86B | ¥1.92B | ¥1.48B | ¥1.95B |
| Long-term borrowings | ¥436.3M | — | ¥1.94B | — | ¥12.5B |
| Total liabilities | ¥8.42B | ¥8.4B | ¥9.36B | ¥8.62B | ¥36.8B |
| Non-controlling interests | ¥815.3M | ¥1.05B | ¥1.2B | ¥1.41B | ¥1.87B |
| Equity attributable to owners of parent | ¥3.52B | ¥3.67B | ¥3.4B | ¥3.23B | ¥26.8B |
| Retained earnings | ¥1.23B | ¥1.38B | ¥1.09B | ¥921M | ¥24.5B |
| Treasury stock | -¥59.2M | -¥58M | -¥52.9M | -¥49.8M | -¥74.5M |
EDINET (FSA Japan)
有価証券報告書－第99期(2025/04/01－2026/03/31)
EDINET (FSA Japan)
有価証券報告書－第98期(2024/04/01－2025/03/31)
EDINET (FSA Japan)
有価証券報告書－第97期(2023/04/01－2024/03/31)
EDINET (FSA Japan)
訂正有価証券報告書－第96期(2022/04/01－2023/03/31)
EDINET (FSA Japan)
有価証券報告書－第95期(令和3年4月1日－令和4年3月31日)
EDINET (FSA Japan)
訂正有価証券報告書－第94期(令和2年4月1日－令和3年3月31日)
Extracted from XBRL: 53 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.